Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?

Coronavirus disease 2019 (COVID-19) is now at the forefront of major health challenge faced globally, creating an urgent need for safe and efficient therapeutic strategies. Given the high attrition rates, high costs, and quite slow development of drug discovery, repurposing of known FDA-approved mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Devaux, Christian A., Melenotte, Cléa, Piercecchi-Marti, Marie-Dominique, Delteil, Clémence, Raoult, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450353/
https://www.ncbi.nlm.nih.gov/pubmed/34552938
http://dx.doi.org/10.3389/fmed.2021.663708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450353/
https://www.ncbi.nlm.nih.gov/pubmed/34552938
http://dx.doi.org/10.3389/fmed.2021.663708

Ejemplares similares